ACTIVATOR相关论文
为满足现代工程应用的要求,需要精确控制碱激发水泥(AAC)流变性能的时变特性.本文研究了激发剂Na2O浓度和SiO2/Na2O(S/N)摩尔比对......
The influences of concentration and modulus of sodium silicate solution and curing mode on the phase composition,microst......
Using slag, steel slag and Portland cement as the raw material with a small amount of activator, the composite Portland ......
Early hydration of alkali–activated slag cement(AASC)is different from Portland cement.Effects of activator type,modulu......
The effect of activator and its dosage on the early hydration and setting performances of alkali-activated slag cement (......
In order to overcome the difficulty of extracting gold from gold-bearing sulfide ore by cyanide process, the flotation w......
Calcium-activated Chloride Channels (CaCCs), TMEM16A, control diverse functions in nociception, neuronal excitability, m......
Antibiotics has added an average of 20 years to our life.Unfortunately,bacteria are resistant to almost all antibiotics....
Most studies of drug discovery today are focused on developing small-molecule inhibitors and only small number of enzyme......
很少有研究对接受急性卒中治疗的80岁以上患者的临床转归进行探讨。美国哥伦比亚大学的Willey等进行了一项研究，对≥80岁的患者与年......
尽管存在早期有症状颅内出血（symptomatic intracranial hemorrhage，slCH）风险，但静脉重组组织型纤溶酶原激活剂（recombinant tissue-ty......
根据第23届欧洲卒中大会（European Stroke Conference，ESC）报道的一项回顾性研究结果，大脑中动脉（middle cerebral artery，MCA）M1段闭塞长......
静脉组织型纤溶酶原激活剂（tisue plasminogen activator，tPA）治疗急性缺血性卒中（acute ischemicstroke，AIS）的获益呈时间依赖性，指南建......
2004年7月至2007年6月，德国海德堡大学的F6rster等在发病3h内接受重组组织型纤溶酶原激活物（recombinant tissue plasminogen activa......
美国密歇根州立大学的Archit等进行的一项汇总分析表明，急性缺血性卒中（acute ischemic stroke，AIS）发病后，女性接受组织型纤溶酶原激活......
女性的卒中自然史比男性更差。有关不同性别缺血性卒中患者接受重组组织型纤溶酶原激活物（recombinant tissue plasminogen activat......
急性缺血性卒中患者（acute ischemic stroke，AIS）的血压通常升高。当需要积极的措施，如持续输注盐酸尼卡地平来维持血压低于110／185mm H......
替奈普酶（tenecteplase，TNK）是组织型纤溶酶原激活剂（tissue plasminogen activator，tPA）的一种改良形式，其半衰期更长，与纤维蛋白的亲和力......
虽然医院的经验对重组组织型纤溶酶原激活剂（recombinant tissue plasminogen activator，rtPA）治疗急性缺血性卒中后的患者生存率有影......
组织型纤溶酶原激活剂（tissue plasminogen activator，tPA）是美国食品药品管理局批准用于缺血性卒中紧急治疗的唯一一种溶栓药，但仅限......
急性缺血性卒中患者在接受静脉重组组织型纤溶酶原激活剂（recombinant tissue plasminogen activator rt-PA）治疗后可能会出现临床恶......
业已证实，2MHz经颅多普勒（transcranial Doppler，TCD）持续监测可增强急性颅内动脉闭塞患者的静脉溶栓效果。据推测，其机制可能是由于超......
在3h内应用重组组织型纤溶酶原激活剂（recombinant tissue plasminogen activator，rtPA）静脉溶栓的随机对照试验通常将老年卒中患者排......
目的应用CBCT(Cone-beamComputedTomography，锥体束计算机断层扫描)测量，分析青春发育高峰期的安氏Ⅱ类下颌后缩患者使用Activator矫......
Effects on the STAT3-shRNA in Non-Small-Cell Lung Cancer Therapy: Design, Induction of Apoptosis, an
STAT3 plays a particularly important role in several cancer-related signal transduction pathways.Silencing STAT3 via RNA......
Most studies of drug discovery today are focused on developing small-molecule inhibitors and only small number of en......
目的探讨口服避孕药(Oral Contraceptive,OC)暴露、纤溶酶原激活物抑制剂1(Plasminogen Activator Inhibitor-1,PAI-1)基因多态性......
Inhibitory effect of 3’-untranslated region (3’-UTR) of human tissue-plasminogen activator (ht-PA) m
A series of t-PA cDNA mutants containing different parts of 3’-UTR sequences have beenconstructed.In vitro translation ......
Three tissue-type plasminogen activator(t-PA)mutants were constructed by recombinant andsite-directed mutagenesis techni......
Sol-gel Processing of a Transparent Upconversion Luminescent Film with β-Na YF_4:Yb~(3+), Er~(3+) Mi
β-Na YF4:Yb3+,Er3+ microrods were synthesized through hydrothermal methods. Polyethylene glycol with molecular weight o......
Implication of Receptor Activator of NF-κB Ligand in Wnt/β-Catenin Pathway Promoting Osteoblast-like
Recent studies showed that activation of Wnt/β-catenin pathway promoted the differentiation of osteoblast-like cells in......
英国朗文出版公司出版过许多优秀辞书 ,其中1978年出版的ＬｏｎｇｍａｎＤｉｃｔｉｏｎａｒｙｏｆＣｏｎｔｅｍｐｏｒａｒｙＥｎｇｌｉｓｈ就是一部好辞书 ,至今仍是我国英语学习者 ,尤其是英语教学工作者必备的一......
Inorganic ChemistrySynthesis of Silica Molecular Sieves and Their U se in Fine Chemicals 14 ( 1) ,0 0 1The Research Prog......
Role of Carbonic Anhydrase as an Activator in Carbonate Rock Dissolution and Its Implication for Atm
The conversion of CO2 into H+ and is a relatively slow reaction. Hence, its kinetics may be rate determiningin carbonat......
An updated meta-analysis of the signal transducer and activator of transcription 4 (STAT4) rs7574865
...
目的 activator矫治器在安氏Ⅱ类错颌治疗中的疗效及应用特点.方法 23名9-13岁的以下颌后缩为主的安氏Ⅱ类错颌患者应用activator......
骨保护素(osteoprotegerin,OPG)是肿瘤坏死因子(TNF)受体家族的成员之一,与核因子-κB受体活化因子配体(receptor activator of nu......
目的：观察activator肌激动器治疗安Ⅱ2错合的疗效。方法对11例替牙期安Ⅱ2错合患者，以activator肌激动器进行矫治。分别于治疗前、治......
目的:采用改良型Activator矫治儿童安氏Ⅱ类错牙合,以评价矫治器对颅、颌面软硬组织的影响.方法:改良型Activator矫治20例安氏Ⅱ类......
欧洲式的矫正器是施用自然力对骨质的改变予以矫正的。牙槽骨最易受改变,基骨亦可以受到大小、形状以及空间关系的改变。使用这种......
Activator是一种基本的功能性矫正器,主要用于调整基骨关系,适于矫正安氏Ⅱ~1、Ⅱ~2、Ⅲ类错(牙合)畸形,对Ⅱ~1有较好的疗效。我......
动物实验研究发现功能性矫治器(FunctionalAppliance,FA)能有效地增长下颌骨长度,一些学者应用klerbst、Frankel和Activator矫治......
改良型Ａｃｔｉｖａｔｏｒ在安氏Ⅱ类Ⅰ分类错合早期矫治中的应用浙江省人民医院（３１００１４）戴淳安氏Ⅱ类Ⅰ分类错病人因开唇露齿、上颌前突、上前牙唇倾、下颌后......
肌激动器(Activator)是一种功能性矫治器.该装置能够传递口腔周围肌肉的力量来移动下颌骨或移动个别牙齿.自1936年由Andresen首先......
Ａｃｔｉｖａｔｏｒ结合Ｈｅａｄｇｅａｒ矫治器的制作与应用牛百平，叶湘玉１９６５年Ｓｔｏｃｋｌｉ、Ｔｅｕｓｃｈｅｒｅ开始应用Ａｃｔｉｖａｔｏｒ结合Ｈｅａｄｇｅａｒ治疗Ⅱ类错［１］，经过长期不断的改进与应用，取得了满意的效果。此方法主要对上下颌......
Headgear-Activator是一种将肌激动器与高位牵引头帽联合应用的矫正器,主要优点是通过调整口外力的作用点、大小和方向,与肌激动器......
